Worldquant Millennium Advisors LLC Alnylam Pharmaceuticals, Inc. Transaction History

Worldquant Millennium Advisors LLC

$19.2 Billion
Q2 2025

A detailed history of Worldquant Millennium Advisors LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Worldquant Millennium Advisors LLC holds 117,373 shares of ALNY stock, worth $56.5 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

117,373

Previous 191,105 38.58%

Holding current value

$56.5 Million

Previous $51.6 Million 25.83%

% of portfolio

0.2%

Previous 0.34%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$224.32 - $326.09 $16.5 Million - $24 Million	-73,732 Reduced 38.58%	117,373 $38.3 Million
Q1 2025 May 15, 2025	BUY	$233.07 - $290.7 $9.54 Million - $11.9 Million	40,914 Added 27.24%	191,105 $51.6 Million
Q4 2024 Feb 14, 2025	BUY	$232.27 - $300.43 $21.3 Million - $27.5 Million	91,671 Added 156.65%	150,191 $35.3 Million
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $16.6 Million - $20.4 Million	-71,073 Reduced 54.84%	58,520 $16.1 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $9.96 Million - $17.2 Million	69,520 Added 115.73%	129,593 $31.5 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $130,979 - $177,190	-894 Reduced 1.47%	60,073 $8.98 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $9.23 Million - $12 Million	60,967 New	60,967 $11.7 Million
Q2 2023 Aug 14, 2023	BUY	$185.01 - $212.05 $4.06 Million - $4.65 Million	21,949 Added 119.69%	40,287 $7.65 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $3.35 Million - $4.32 Million	18,338 New	18,338 $3.67 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $2.83 Million - $4.74 Million	20,426 New	20,426 $4.09 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $5.43 Million - $6.65 Million	-31,999 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $420,748 - $578,607	3,271 Added 11.39%	31,999 $5.42 Million
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $1.69 Million - $2.31 Million	-13,951 Reduced 32.69%	28,728 $4.18 Million
Q2 2020 Aug 14, 2020	BUY	$104.21 - $156.44 $680,803 - $1.02 Million	6,533 Added 18.07%	42,679 $6.32 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $2.18 Million - $3.14 Million	23,424 Added 184.12%	36,146 $3.93 Million
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $947,916 - $1.58 Million	12,722 New	12,722 $1.47 Million

Others Institutions Holding ALNY

# of Institutions

759

Shares Held

115M

Call Options Held

584K

Put Options Held

661K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $59.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Worldquant Millennium Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worldquant Millennium Advisors LLC with notifications on news.

Account

Worldquant Millennium Advisors LLC Alnylam Pharmaceuticals, Inc. Transaction History